416 related articles for article (PubMed ID: 20572907)
21. Optimizing brain MRI protocols in the follow-up of patients with multiple sclerosis T2-weighted MRI of the brain after the administration of gadopentetate dimeglumine.
Taschner CA; Kirsch EC; Scheffler K; Wetzel SG; Schulte-Mönting J; Kappos L; Radü EW
Magn Reson Imaging; 2005 Apr; 23(3):469-74. PubMed ID: 15862648
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors of tumefactive demyelinating lesions and differential features for multiple sclerosis in etiology.
Saridas F; Mesut G; Ceylan CY; Ozpar R; Ozsen M; Koc ER; Tolunay S; Hakyemez B; Turan OF
Mult Scler Relat Disord; 2024 May; 85():105537. PubMed ID: 38460252
[TBL] [Abstract][Full Text] [Related]
23. Spectroscopic magnetic resonance imaging of a tumefactive demyelinating lesion.
Law M; Meltzer DE; Cha S
Neuroradiology; 2002 Dec; 44(12):986-9. PubMed ID: 12483443
[TBL] [Abstract][Full Text] [Related]
24. [Application of 1H-magnetic resonance spectroscopy in differential diagnosis of brain low-grade gliomas and demyelinating diseases].
Hou XY; Gao PY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):206-9. PubMed ID: 19507601
[TBL] [Abstract][Full Text] [Related]
25. [Magnetic resonance imaging of disseminated sclerosis].
Christiansen AP; Wanscher B; Larsson HB; Henriksen O
Ugeskr Laeger; 1994 Oct; 156(43):6348-52. PubMed ID: 7810007
[TBL] [Abstract][Full Text] [Related]
26. Tumefactive demyelinating lesion. Trying to find unity in diversity. Comparison of two cases.
Adamek D; Radwanska E; Rog T; Grzywna E; Herman-Sucharska I
Clin Neurol Neurosurg; 2014 Jan; 116():90-2. PubMed ID: 24269051
[No Abstract] [Full Text] [Related]
27. Focal eosinophilic infiltration of the liver: gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging.
Ahn SJ; Choi JY; Kim KA; Kim MJ; Baek SE; Kim JH; Song HT
J Comput Assist Tomogr; 2011; 35(1):81-5. PubMed ID: 21160434
[TBL] [Abstract][Full Text] [Related]
28. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
Gonzalez-Scarano F; Grossman RI; Galetta S; Atlas SW; Silberberg DH
Ann Neurol; 1987 Mar; 21(3):300-6. PubMed ID: 3606036
[TBL] [Abstract][Full Text] [Related]
29. Tumefactive demyelinating lesion: experience with two unusual patients.
Sinha MK; Garg RK; Bhatt ML; Chandra A
J Postgrad Med; 2010; 56(2):146-9. PubMed ID: 20622396
[TBL] [Abstract][Full Text] [Related]
30. [Diagnosis of pediatric multiple sclerosis initially presenting with tumefactive demyelinating lesion using ¹H-magnetic resonance spectroscopy].
Kageyama T; Gotoh Y; Sano F; Katoh T; Nambu M; Okada T; Suenaga T
Rinsho Shinkeigaku; 2011 Sep; 51(9):688-93. PubMed ID: 21946426
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery and delayed contrast-enhanced brain MRI in multiple sclerosis.
Bagheri MH; Meshksar A; Nabavizadeh SA; Borhani-Haghighi A; Ashjazadeh N; Nikseresht AR
Acad Radiol; 2008 Jan; 15(1):15-23. PubMed ID: 18078903
[TBL] [Abstract][Full Text] [Related]
32. A case of pediatric tumefactive demyelinating lesion misdiagnosed and treated as glioblastoma.
Riva D; Chiapparini L; Pollo B; Balestrini MR; Massimino M; Milani N
J Child Neurol; 2008 Aug; 23(8):944-7. PubMed ID: 18344459
[TBL] [Abstract][Full Text] [Related]
33. [Aphasia and parietal syndrome as the presenting symptoms of a demyelinating disease with pseudotumoral lesions].
Navarro S; Mondéjar-Marín B; Pedrosa-Guerrero A; Pérez-Molina I; Garrido-Robres JA; Alvarez-Tejerina A
Rev Neurol; 2005 Nov 16-30; 41(10):601-3. PubMed ID: 16288423
[TBL] [Abstract][Full Text] [Related]
34. Role of diffusion tensor imaging metrics and in vivo proton magnetic resonance spectroscopy in the differential diagnosis of cystic intracranial mass lesions.
Nath K; Agarwal M; Ramola M; Husain M; Prasad KN; Rathore RK; Pandey CM; Gupta RK
Magn Reson Imaging; 2009 Feb; 27(2):198-206. PubMed ID: 18687551
[TBL] [Abstract][Full Text] [Related]
35. MRI in the diagnosis of pediatric multiple sclerosis.
Callen DJ; Shroff MM; Branson HM; Lotze T; Li DK; Stephens D; Banwell BL
Neurology; 2009 Mar; 72(11):961-7. PubMed ID: 19038852
[TBL] [Abstract][Full Text] [Related]
36. [Magnetic resonance in the diagnosis and treatment of multiple sclerosis].
Rovira Cañellas A
Neurologia; 2000; 15(7):288-302. PubMed ID: 11075577
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of time-intensity curves in ductal carcinoma in situ (DCIS) and mastopathy obtained using dynamic contrast-enhanced magnetic resonance imaging.
Nishiura M; Yasuhiro T; Murase K
Magn Reson Imaging; 2011 Jan; 29(1):99-105. PubMed ID: 20833496
[TBL] [Abstract][Full Text] [Related]
38. Tumefactive demyelinating lesions: a retrospective cohort study in Thailand.
Ongphichetmetha T; Aungsumart S; Siritho S; Apiwattanakul M; Tanboon J; Rattanathamsakul N; Prayoonwiwat N; Jitprapaikulsan J
Sci Rep; 2024 Jan; 14(1):1426. PubMed ID: 38228919
[TBL] [Abstract][Full Text] [Related]
39. Tumefactive demyelinating lesions: A comprehensive review.
Algahtani H; Shirah B; Alassiri A
Mult Scler Relat Disord; 2017 May; 14():72-79. PubMed ID: 28619436
[TBL] [Abstract][Full Text] [Related]
40. [Neuroimaging and functional analyses for multiple sclerosis].
Kira J
Rinsho Byori; 2000 Sep; 48(9):814-22. PubMed ID: 11051795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
